This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Importin
From Proteopedia
(Difference between revisions)
| Line 38: | Line 38: | ||
**[[4xzr]] – yIPO NLS-binding domain + HEH1<br /> | **[[4xzr]] – yIPO NLS-binding domain + HEH1<br /> | ||
**[[4pvz]] – yIPO NLS-binding domain + HEH2<br /> | **[[4pvz]] – yIPO NLS-binding domain + HEH2<br /> | ||
| - | **[[4rxh]] – | + | **[[4rxh]] – NcIPO NLS-binding domain + SV40 large T antigen – ''Neurospora crassa''<br /> |
| + | **[[5vqi]] – NcIPO NLS-binding domain + NIT2<br /> | ||
*''IPO-α complex with protein'' | *''IPO-α complex with protein'' | ||
**[[1wa5]] – yIPO NLS-binding domain + GTPase Ran + IPO-α re-exporter<br /> | **[[1wa5]] – yIPO NLS-binding domain + GTPase Ran + IPO-α re-exporter<br /> | ||
| + | **[[5t94]] – yIPO NLS-binding domain + guanine nucleotide exchange factor <br /> | ||
| + | **[[5mfm]] – yIPO NLS-binding domain + YIIIM6AII <br /> | ||
*IPO-α 1 | *IPO-α 1 | ||
| Line 48: | Line 51: | ||
**[[3wpt]] – hIPO NLS-binding domain - human<br /> | **[[3wpt]] – hIPO NLS-binding domain - human<br /> | ||
**[[4b8j]] – rIPO <br /> | **[[4b8j]] – rIPO <br /> | ||
| + | **[[6bvt]] – mIPO NLS-binding domain <br /> | ||
*''IPO-α 1 complex with NLS peptide'' | *''IPO-α 1 complex with NLS peptide'' | ||
| Line 68: | Line 72: | ||
**[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | **[[4b18]] – hIPO NLS-binding domain + telomerase reverse transcriptase<br /> | ||
**[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | **[[4wv6]] – hIPO NLS-binding domain + TFIID<br /> | ||
| + | **[[6bw0]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | ||
| + | **[[6bw1]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | ||
| + | **[[5w41]] – mIPO NLS-binding domain + Zika virus peptide <br /> | ||
| + | **[[5v5o]], [[5v5p]] – mIPO NLS-binding domain + influenza virus peptide <br /> | ||
| + | **[[5umz]] – mIPO NLS-binding domain + TNRC6A peptide <br /> | ||
| + | **[[5u5p]], [[5u5r]] – mIPO NLS-binding domain + MLH1 peptide <br /> | ||
| + | **[[5gxw]] – mIPO NLS-binding domain + NUMA peptide <br /> | ||
| + | **[[5w4e]], [[5w4f]], [[5w4g]] – hIPO NLS-binding domain + polymerase peptide<br /> | ||
| + | **[[5h43]] – hIPO NLS-binding domain + histone acetyltransferase KAT8<br /> | ||
**[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | **[[4b8o]] – rIPO NLS-binding domain + SV40<br /> | ||
**[[4b8p]] – rIPO NLS-binding domain + A89<br /> | **[[4b8p]] – rIPO NLS-binding domain + A89<br /> | ||
| Line 116: | Line 129: | ||
*IPO-α 3 | *IPO-α 3 | ||
| + | **[[6bvz]] – hIPO NLS-binding domain <br /> | ||
**[[4uae]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | **[[4uae]] – hIPO NLS-binding domain + influenza RNA polymerase<br /> | ||
| + | **[[6bw9]], [[6bwa]], [[6bwb]] – hIPO NLS-binding domain + Hendra virus peptide<br /> | ||
| + | **[[6bvv]] – hIPO NLS-binding domain + Nipa virus peptide<br /> | ||
| + | **[[5xzx]] – hIPO NLS-binding domain + RAN-binding protein peptide<br /> | ||
| + | **[[5tbk]] – hIPO NLS-binding domain + regulator of chromosome condensation <br /> | ||
*IPO-α 6 | *IPO-α 6 | ||
| Line 157: | Line 175: | ||
**[[2z5o]] – hIPO + JKTBP peptide<br /> | **[[2z5o]] – hIPO + JKTBP peptide<br /> | ||
**[[4fdd]], [[4jlq]], [[4oo6]] – hIPO + RNA binding protein peptide<br /> | **[[4fdd]], [[4jlq]], [[4oo6]] – hIPO + RNA binding protein peptide<br /> | ||
| + | **[[5yvg]], [[5yvh]] – hIPO + FUS <br /> | ||
| + | **[[5vyh]], [[5vyi]] – hIPO + FUS peptide<br /> | ||
**[[4fq3]] – hIPO + FUS peptide<br /> | **[[4fq3]] – hIPO + FUS peptide<br /> | ||
**[[5tqc]] – hIPO + RPL4 peptide<br /> | **[[5tqc]] – hIPO + RPL4 peptide<br /> | ||
| Line 171: | Line 191: | ||
**[[5h2v]] – yIPO + ubiquitin-like specific protease<br /> | **[[5h2v]] – yIPO + ubiquitin-like specific protease<br /> | ||
**[[4zj7]] – yIPO + CDC14<br /> | **[[4zj7]] – yIPO + CDC14<br /> | ||
| + | |||
| + | *IPO-4B | ||
| + | |||
| + | **[[5xah]] – hIPO residues 668-1081 <br /> | ||
| + | **[[5xbk]] – hIPO residues 668-1081 + histone H3 peptide <br /> | ||
*IPO-12 (Transportin-3) | *IPO-12 (Transportin-3) | ||
Revision as of 08:10, 19 July 2018
| |||||||||||
3D structures of importin
Updated on 19-July-2018
References
- ↑ Mattaj IW, Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem. 1998;67:265-306. PMID:9759490 doi:http://dx.doi.org/10.1146/annurev.biochem.67.1.265
- ↑ Pumroy RA, Cingolani G. Diversification of importin-alpha isoforms in cellular trafficking and disease states. Biochem J. 2015 Feb 15;466(1):13-28. doi: 10.1042/BJ20141186. PMID:25656054 doi:http://dx.doi.org/10.1042/BJ20141186

